Influence of 5-aminosalicylic acid and N-Acetylmesalamine in Japanese patients with ulcerative colitis

Yuki Yamamoto, Satohiro Masuda, Hiroshi Nakase, Minoru Matsuura, Shihoko Maruyama, Tadakazu Hisamatsu, Yasuo Suzuki, Kazuo Matsubara

研究成果: ジャーナルへの寄稿記事

抄録

The efficacy of 5-aminosalicylic acid (5-ASA) as the first-line therapy for ulcerative colitis (UC) is determined by the extent of drug delivery to the inflamed region. Moreover, differences among the various formulations influence delivery of the drug. In this study, we examined the clinical significance of colonic mucosal concentrations of 5-ASA and N-acetylmesalamine (Ac-5-ASA) in UC patients receiving a pH-dependent or time-dependent release formulation of 5-ASA. The subjects were 67 patients with UC who were treated with a pH-dependent or time-dependent formulation of 5-ASA between December 2011 and April 2014. A retrospective observational analysis of clinical outcomes was performed using the clinical activity index (CAI) obtained on the day of biopsy. Colonic mucosal concentrations of 5-ASA and Ac-5-ASA in biopsy samples were measured by LC-tandem mass spectrometry/mass spectrometry. Patients who were treated with the pH-dependent formulation had higher colon mucosal concentrations of 5-ASA than those who were treated with the time-dependent formulation. Additionally, 5-ASA concentration was significantly higher in patients with CAI scores 3. A higher concentration of Ac-5-ASA was achieved with the time-dependent formulation than with the pH-dependent formulation. Furthermore, patients with CAI scores 3 had higher concentrations of 5-ASA than those with CAI scores 4. The colonic mucosal concentration of 5-ASA in patients with UC is influenced by the pharmaceutical formulation and the remission status of UC.

元の言語英語
ページ(範囲)81-86
ページ数6
ジャーナルBiological and Pharmaceutical Bulletin
42
発行部数1
DOI
出版物ステータス出版済み - 1 1 2019

Fingerprint

Mesalamine
Ulcerative Colitis
Tandem Mass Spectrometry
Biopsy
Drug Compounding
Pharmaceutical Preparations
Colon

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

これを引用

Influence of 5-aminosalicylic acid and N-Acetylmesalamine in Japanese patients with ulcerative colitis. / Yamamoto, Yuki; Masuda, Satohiro; Nakase, Hiroshi; Matsuura, Minoru; Maruyama, Shihoko; Hisamatsu, Tadakazu; Suzuki, Yasuo; Matsubara, Kazuo.

:: Biological and Pharmaceutical Bulletin, 巻 42, 番号 1, 01.01.2019, p. 81-86.

研究成果: ジャーナルへの寄稿記事

Yamamoto, Y, Masuda, S, Nakase, H, Matsuura, M, Maruyama, S, Hisamatsu, T, Suzuki, Y & Matsubara, K 2019, 'Influence of 5-aminosalicylic acid and N-Acetylmesalamine in Japanese patients with ulcerative colitis', Biological and Pharmaceutical Bulletin, 巻. 42, 番号 1, pp. 81-86. https://doi.org/10.1248/bpb.b18-00561
Yamamoto, Yuki ; Masuda, Satohiro ; Nakase, Hiroshi ; Matsuura, Minoru ; Maruyama, Shihoko ; Hisamatsu, Tadakazu ; Suzuki, Yasuo ; Matsubara, Kazuo. / Influence of 5-aminosalicylic acid and N-Acetylmesalamine in Japanese patients with ulcerative colitis. :: Biological and Pharmaceutical Bulletin. 2019 ; 巻 42, 番号 1. pp. 81-86.
@article{8937601c8dcb4130bc86b0f6df17796a,
title = "Influence of 5-aminosalicylic acid and N-Acetylmesalamine in Japanese patients with ulcerative colitis",
abstract = "The efficacy of 5-aminosalicylic acid (5-ASA) as the first-line therapy for ulcerative colitis (UC) is determined by the extent of drug delivery to the inflamed region. Moreover, differences among the various formulations influence delivery of the drug. In this study, we examined the clinical significance of colonic mucosal concentrations of 5-ASA and N-acetylmesalamine (Ac-5-ASA) in UC patients receiving a pH-dependent or time-dependent release formulation of 5-ASA. The subjects were 67 patients with UC who were treated with a pH-dependent or time-dependent formulation of 5-ASA between December 2011 and April 2014. A retrospective observational analysis of clinical outcomes was performed using the clinical activity index (CAI) obtained on the day of biopsy. Colonic mucosal concentrations of 5-ASA and Ac-5-ASA in biopsy samples were measured by LC-tandem mass spectrometry/mass spectrometry. Patients who were treated with the pH-dependent formulation had higher colon mucosal concentrations of 5-ASA than those who were treated with the time-dependent formulation. Additionally, 5-ASA concentration was significantly higher in patients with CAI scores 3. A higher concentration of Ac-5-ASA was achieved with the time-dependent formulation than with the pH-dependent formulation. Furthermore, patients with CAI scores 3 had higher concentrations of 5-ASA than those with CAI scores 4. The colonic mucosal concentration of 5-ASA in patients with UC is influenced by the pharmaceutical formulation and the remission status of UC.",
author = "Yuki Yamamoto and Satohiro Masuda and Hiroshi Nakase and Minoru Matsuura and Shihoko Maruyama and Tadakazu Hisamatsu and Yasuo Suzuki and Kazuo Matsubara",
year = "2019",
month = "1",
day = "1",
doi = "10.1248/bpb.b18-00561",
language = "English",
volume = "42",
pages = "81--86",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "1",

}

TY - JOUR

T1 - Influence of 5-aminosalicylic acid and N-Acetylmesalamine in Japanese patients with ulcerative colitis

AU - Yamamoto, Yuki

AU - Masuda, Satohiro

AU - Nakase, Hiroshi

AU - Matsuura, Minoru

AU - Maruyama, Shihoko

AU - Hisamatsu, Tadakazu

AU - Suzuki, Yasuo

AU - Matsubara, Kazuo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The efficacy of 5-aminosalicylic acid (5-ASA) as the first-line therapy for ulcerative colitis (UC) is determined by the extent of drug delivery to the inflamed region. Moreover, differences among the various formulations influence delivery of the drug. In this study, we examined the clinical significance of colonic mucosal concentrations of 5-ASA and N-acetylmesalamine (Ac-5-ASA) in UC patients receiving a pH-dependent or time-dependent release formulation of 5-ASA. The subjects were 67 patients with UC who were treated with a pH-dependent or time-dependent formulation of 5-ASA between December 2011 and April 2014. A retrospective observational analysis of clinical outcomes was performed using the clinical activity index (CAI) obtained on the day of biopsy. Colonic mucosal concentrations of 5-ASA and Ac-5-ASA in biopsy samples were measured by LC-tandem mass spectrometry/mass spectrometry. Patients who were treated with the pH-dependent formulation had higher colon mucosal concentrations of 5-ASA than those who were treated with the time-dependent formulation. Additionally, 5-ASA concentration was significantly higher in patients with CAI scores 3. A higher concentration of Ac-5-ASA was achieved with the time-dependent formulation than with the pH-dependent formulation. Furthermore, patients with CAI scores 3 had higher concentrations of 5-ASA than those with CAI scores 4. The colonic mucosal concentration of 5-ASA in patients with UC is influenced by the pharmaceutical formulation and the remission status of UC.

AB - The efficacy of 5-aminosalicylic acid (5-ASA) as the first-line therapy for ulcerative colitis (UC) is determined by the extent of drug delivery to the inflamed region. Moreover, differences among the various formulations influence delivery of the drug. In this study, we examined the clinical significance of colonic mucosal concentrations of 5-ASA and N-acetylmesalamine (Ac-5-ASA) in UC patients receiving a pH-dependent or time-dependent release formulation of 5-ASA. The subjects were 67 patients with UC who were treated with a pH-dependent or time-dependent formulation of 5-ASA between December 2011 and April 2014. A retrospective observational analysis of clinical outcomes was performed using the clinical activity index (CAI) obtained on the day of biopsy. Colonic mucosal concentrations of 5-ASA and Ac-5-ASA in biopsy samples were measured by LC-tandem mass spectrometry/mass spectrometry. Patients who were treated with the pH-dependent formulation had higher colon mucosal concentrations of 5-ASA than those who were treated with the time-dependent formulation. Additionally, 5-ASA concentration was significantly higher in patients with CAI scores 3. A higher concentration of Ac-5-ASA was achieved with the time-dependent formulation than with the pH-dependent formulation. Furthermore, patients with CAI scores 3 had higher concentrations of 5-ASA than those with CAI scores 4. The colonic mucosal concentration of 5-ASA in patients with UC is influenced by the pharmaceutical formulation and the remission status of UC.

UR - http://www.scopus.com/inward/record.url?scp=85059500685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059500685&partnerID=8YFLogxK

U2 - 10.1248/bpb.b18-00561

DO - 10.1248/bpb.b18-00561

M3 - Article

VL - 42

SP - 81

EP - 86

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 1

ER -